Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-097147
Filing Date
2024-08-14
Accepted
2024-08-14 16:56:30
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7030
  Complete submission text file 0000950170-24-097147.txt   8580
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Business Address
Ber Gerard (Reporting) CIK: 0001762144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 241209180